tiprankstipranks
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX

Lineage Therap (LCTX) Financial Statements

1,775 Followers

Lineage Therap Financial Overview

Lineage Therap's market cap is currently ―. The company's EPS TTM is $-0.124; its P/E ratio is -11.23; Lineage Therap is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 2.15M$ 1.20M$ 3.20M$ 2.40M$ 1.90M
Gross Profit$ 1.89M$ 1.03M$ 3.10M$ 2.27M$ 1.81M
EBIT$ -3.61M$ -7.59M$ -5.58M$ -6.21M$ -6.76M
EBITDA$ -3.46M-$ -5.42M$ -6.04M$ -7.04M
Net Income Common Stockholders$ -4.78M$ -7.11M$ -5.23M$ 13.44M$ -6.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 35.49M$ 41.37M$ 45.92M$ 46.81M$ 57.88M
Total Assets$ 101.02M$ 106.15M$ 111.69M$ 113.00M$ 123.66M
Total Debt$ 2.95M$ 3.08M$ 3.40M$ 3.64M$ 3.90M
Net Debt$ -32.54M$ -38.29M$ -42.52M$ -43.18M$ -53.98M
Total Liabilities$ 39.00M$ 39.49M$ 40.43M$ 44.19M$ 51.73M
Stockholders Equity$ 63.42M$ 68.12M$ 72.67M$ 70.45M$ 73.34M
Cash Flow-
Free Cash Flow$ -6.11M-$ -6.52M$ -11.43M$ -8.29M
Operating Cash Flow$ -6.02M$ -5.04M$ -6.27M$ -11.24M$ -8.30M
Investing Cash Flow$ 9.74M$ 2.12M$ 19.16M$ 15.43M$ -5.10M
Financing Cash Flow$ -13.00K$ 807.00K$ 5.63M$ 1.00K$ 122.00K
Currency in USD

Lineage Therap Earnings and Revenue History

Lineage Therap Debt to Assets

Lineage Therap Cash Flow

Lineage Therap Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis